Michael Miller Wins 2021 Shelanski Research Innovation Award in Pathology
We are pleased to announce that Michael Miller, MD, PhD, a postdoctoral neuropathology fellow, is the winner of the 2021 Shelanski Research Innovation Award in Pathology for his proposal titled: “Rosette-forming glioneuronal tumors (RGNT) are rare brain tumors primarily seen in children and young adults”.
The Shelanski Research Innovation Award in Pathology was established in 2017 with an eye to supporting the development of innovative research ideas and concepts contributed by fellows and residents within the Department of Pathology and Cell Biology in their research projects that further our understanding of mechanisms of biology and pathophysiology of disease. So far, besides Dr. Miller, the following pathology fellows/residents have received this award:
2017 - Osama Al Dalahmah, for his proposal titled: Glial Heterogeneity in Health and Huntington’s Disease;
2018 - Paul (Chun Chieh) Lin, for his proposal titled: Deciphering Multifactorial Genetic Contributions for Motor Neuron Development;
2020 - Marie Smithgall, for her proposal titled: Investigation of Discrepant MMR IHC and MSI PCR Test Results for Gynecologic Cancers; and
Congratulations to all of them!
Supported by gifts from the Ralph Abrams Fund (from Anatomy and Cell Biology) and the Herman Shelanski Memorial Fund, this competitive award program is designed to support the development of innovative research ideas and concepts contributed by fellows and residents within the Department of Pathology and Cell Biology. Funds is made available for Residents and Fellows in Pathology to support innovative research projects that further our understanding of mechanisms of biology and pathophysiology of disease. Applications are accepted on an open/rolling basis. Once documents are received the application is reviewed and rated by a committee of faculty and staff. Final decision is made and applicant is advised if awarded.
The award provides up to $5,000 to defray the cost for supplies and services for research projects to be conducted during the fiscal year of the award.
Applications are accepted and evaluated each fiscal year on an open/rolling basis. Interested applicants may submit as research teams or individuals, a 3-4 page (no more than 3000 words) proposal (excluding references) including background, central hypothesis, detailed specific aims, and a discussion of the expected outcome, significance, novelty, impact, and possible anticipated pitfalls to the approach. Applicants must also submit their current CV and a letter of support from their mentor(s) that provides a statement describing their support for the research and how participation and successful completion of the proposed research will be important for the career development of the applicant(s).
Please address inquiries to email@example.com